Effect of two high dose vitamin D by parenteral route in treating vitamin D deficiency a prospective interventional study.

What Was Tested

This clinical trial looks at Vitamin D, K2, Magnesium and Zinc.

To find a simple, affordable and practical plan to treat vitamin-d deficiency.

Why It Was Studied

Vitamin D deficiency is recognized as a global public health problem.

Despite ample sunshine, vitamin D deficiency is very common in the Middle East (15°-36°N) and African (35°S-37°N) countries; and in South Asian countries.

Who Took Part

The study group was 80 women.

The age groups tagged for this paper are young adults, adults and middle-aged adults, women only.

80 Women participated in study.

How the Study Was Run

Laboratory tests: Vitamin D [25-OHD]-estimations were performed with LCMSMS-liquid chromatography tandem mass spectrometry.

What Was Measured

The subject headings attached to it are Birth Weight, Infusions, Parenteral, Parity, Pregnancy Complications, Vitamin D and Vitamin D Deficiency.

Author keywords: Genetic factors-VDBP, high hydroxylase enzyme activity, treatment of vitamin D deficiency and variable responses.

What This Means in Plain Language

This is a clinical trial of Vitamin D, K2, Magnesium and Zinc in 80 women.

Its findings take up roughly 2 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2018 (The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.